AAAAAA
Results:
1-22
|
Results: 22
Authors:
MORABITO F
STELITANO C
CALLEA I
DATTOLA A
CONSOLE G
PUCCI G
IACOPINO P
CALLEA V
DIRAIMONDO F
BRUGIATELLI M
Citation: F. Morabito et al., IN-VITRO DRUG-INDUCED CYTOTOXICITY PREDICTS CLINICAL-RESPONSE TO FLUDARABINE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(2), 1998, pp. 528-531
Authors:
CALLEA V
COMIS M
IARIA G
SCULLI G
MORABITO F
LOMBARDO VT
Citation: V. Callea et al., CLINICAL-SIGNIFICANCE OF HLA-DR-CELL PHENOTYPE AND CD34(+) CELL DETECTION IN BONE-MARROW LYMPHOCYTES FROM CHILDREN AFFECTED WITH IMMUNE THROMBOCYTOPENIC PURPURA(, CD19(+), CD10(+) IMMATURE B), Haematologica, 82(4), 1997, pp. 471-473
Authors:
CALLEA V
SCULLI G
COMIS M
Citation: V. Callea et al., INCREASED PROPORTION OF CD10-POSITIVE CELLS IN A BOY AFFECTED WITH COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA IN CONSOLIDATION THERAPY, Haematologica, 82(4), 1997, pp. 507-507
Authors:
MORABITO F
FILANGERI M
CALLEA I
SCULLI G
CALLEA V
FRACCHIOLLA NS
NERI A
BRUGIATELLI M
Citation: F. Morabito et al., BCL-2 PROTEIN EXPRESSION AND P53 GENE MUTATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH IN-VITRO SENSITIVITY TO CHLORAMBUCIL AND PURINE ANALOGS, Haematologica, 82(1), 1997, pp. 16-20
Authors:
BRUGIATELLI M
CLAISSE JF
LENORMAND B
MORABITO F
CALLEA V
MALLOUM K
CHEVRET S
BINET JL
DIGHIERO G
TRAVADE P
Citation: M. Brugiatelli et al., LONG-TERM CLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, British Journal of Haematology, 97(1), 1997, pp. 113-118
Authors:
BOCCADORO M
AGENTINO C
AVVISATI G
BALDINI L
BIDOLI P
CAPALDI A
CALLEA V
CIMINO R
COMOTTI B
DERENZO A
DOMINIETTO A
FALINI B
FRIERI R
GALLONE G
GRASSO M
IANNITTO E
LAUTA VM
LIBERATI M
MARCENO R
MARMONT F
MOLICA S
MUSTO P
PALUMBO A
PULSONI A
RUS C
TRIBALTO M
PILERI A
MANDELLI F
Citation: M. Boccadoro et al., MELPHALAN AND PREDNISONE (MP) FOLLOWED BY INTERFERON PLUS DEXAMETHASONE MAINTENANCE THERAPY IMPROVES REMISSION DURATION OF MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 1586-1586
Authors:
JAKSIC B
BRUGIATELLI M
STELITANO C
MORABITO F
CALLEA V
JAKSIC O
PLANINCPERAICA A
LUTZ D
Citation: B. Jaksic et al., CHLORAMBUCIL MAINTENANCE SIGNIFICANTLY IMPROVES SURVIVAL IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - METAANALYSIS OF IGCI CLL TRIALS, Blood, 90(10), 1997, pp. 2362-2362
Authors:
BRUGIATELLI M
HOLOWIECKA B
DMOSZYNSKA A
KRIEGER O
PLANINCPERAICA A
LABAR B
CALLEA V
MORABITO F
JAKSIC B
HOLOWIECKI J
LUTZ D
Citation: M. Brugiatelli et al., 2-CHLORODEOXYADENOSINE TREATMENT IN NON-HODGKINS-LYMPHOMA AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO CONVENTIONAL CHEMOTHERAPY - RESULTS OF A MULTICENTRIC EXPERIENCE, Annals of hematology, 73(2), 1996, pp. 79-84
Authors:
VECCHI A
CAVANNA L
AVANZINI P
CALLEA V
VELARDI A
ALBI N
TARTONI P
BENSI L
VALENTINI P
LONGO R
SACCHI S
Citation: A. Vecchi et al., IN-VIVO BIOLOGICAL RESPONSE FOLLOWING LOW-DOSE INTERLEUKIN-2 IN COMPLETE REMISSION B-CELL NON-HODGKINS-LYMPHOMA PATIENTS, European journal of haematology, 57(1), 1996, pp. 33-37
Authors:
GOBBI PG
PIERESCA C
CAVANNA L
CORBELLA F
VALLISA D
FEDERICO M
FORMISANO R
CAROTENUTO M
MERLI F
CALLEA V
ANGRILLI F
SILINGARDI V
Citation: Pg. Gobbi et al., CCNU, VINBLASTINE, PROCARBAZINE AND PREDNISONE (CVPP) WITH EXTENDED-FIELD RADIOTHERAPY IN THE TREATMENT OF EARLY UNFAVORABLE HODGKINS-DISEASE - A PROSPECTIVE-STUDY ON BEHALF OF THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI (GISL), Haematologica, 81(6), 1996, pp. 503-512
Authors:
CALLEA V
MORABITO F
LUISE F
PIROMALLI A
FILANGERI M
STELITANO C
IACOPINO P
NOBILE F
BRUGIATELLI M
Citation: V. Callea et al., CLINICAL-SIGNIFICANCE OF SIL2R, SCD23, SICAM-1, IL6 AND SCD14 SERUM LEVELS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Haematologica, 81(4), 1996, pp. 310-315
Authors:
MORABITO F
STELITANO C
CALLEA I
FILANGERI M
OLIVA B
SCULLI G
CALLEA V
NOBILE F
BRUGIATELLI M
Citation: F. Morabito et al., IN-VITRO SENSITIVITY OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS TO FLUDARABINE, 2-CHLORODEOXYADENOSINE AND CHLORAMBUCIL - CORRELATION WITH CLINICOHEMATOLOGICAL AND IMMUNOPHENOTYPIC FEATURES, Haematologica, 81(3), 1996, pp. 224-231
Authors:
ANDRIANI A
BIBAS M
CALLEA V
DERENZO A
CHIURAZZI F
MARCENO R
MUSTO P
ROTOLI B
Citation: A. Andriani et al., AUTOIMMUNE HEMOLYTIC-ANEMIA DURING ALPHA-INTERFERON TREATMENT IN 9 PATIENTS WITH HEMATOLOGICAL-DISEASES, Haematologica, 81(3), 1996, pp. 258-260
Authors:
BRUGIATELLI M
JAKSIC B
PLANINCPERAICA A
KUSEC R
OSTOJIC S
CALLEA V
IACOPINO P
MORABITO F
STELITANO C
LUTZ D
Citation: M. Brugiatelli et al., TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA IN EARLY AND STABLE PHASE OF THE DISEASE - LONG-TERM RESULTS OF A RANDOMIZED TRIAL, European journal of haematology, 55(3), 1995, pp. 158-163
Authors:
MORABITO F
CALLEA I
RODINO A
MESSINA G
CALLEA V
IACOPINO P
NOBILE F
BRUGIATELLI M
Citation: F. Morabito et al., MODULATION OF PURINE ANALOGS-INDUCED AND CHLORAMBUCIL-INDUCED CYTOTOXICITY BY ALPHA-INTERFERON AND INTERLEUKIN-2 IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 9(9), 1995, pp. 1450-1455
Authors:
BRUGIATELLI M
CLAISSE JF
LENORMAND B
MORABITO F
CALLEA V
MALLOUM K
CHEVRET S
BINET JL
DIGHIERO G
TRAVADE P
Citation: M. Brugiatelli et al., SCLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, Blood, 86(10), 1995, pp. 1377-1377
Authors:
SACCHI S
CAVANNA L
AVANZINI P
CALLEA V
VELARDI A
ALBI N
TARTONI PL
BENSI L
VALENTINI P
LONGO R
CENCI AM
VECCHI A
Citation: S. Sacchi et al., IN-VIVO BIOLOGICAL RESPONSE FOLLOWING LOW-DOSE INTERLEUKIN-2 IN COMPLETE REMISSION B-CELL NON-HODGKINS-LYMPHOMA PATIENTS, Blood, 86(10), 1995, pp. 3275-3275
Authors:
ROTOLI B
DERENZO A
FRIGERI F
BUFFARDI S
MARCENO R
CAVALLARO AM
RUGGERI P
LISO V
MUSTO P
ANDRIANI A
CALLEA V
PIZZUTI M
IANNITTO E
CIMINO R
MOLICA S
CITARRELLA P
MUSOLINO C
GUARINO S
LUCARELLI G
ESPINOSA A
DELVECCHIO L
Citation: B. Rotoli et al., A PHASE-II TRIAL ON ALPHA-INTERFERON (ALPHA-IFN) EFFECT IN PATIENTS WITH MONOCLONAL IGM GAMMOPATHY, Leukemia & lymphoma, 13(5-6), 1994, pp. 463-469
Authors:
MOLICA S
BRUGIATELLI M
CALLEA V
MORABITO F
LEVATO D
NOBILE F
ALBERTI A
Citation: S. Molica et al., COMPARISON OF YOUNGER VERSUS OLDER B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS FOR CLINICAL PRESENTATION AND PROGNOSIS - A RETROSPECTIVE STUDY OF 53 CASES, European journal of haematology, 52(4), 1994, pp. 216-221
Authors:
MARCENO R
BUSCEMI F
FIANDACA T
MOLICA S
ALBERTI A
RUGGERI P
ARDIZZONE G
DERENZO A
ROTOLI B
IANNITTO E
ABBADESSA V
MUSTO P
CAROTENUTO M
DERIU L
CALLEA V
ANDRIANI A
MUSOLINO C
PIZZUTI M
RENNA S
CARONIA F
Citation: R. Marceno et al., CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CD) VERSUS CD-PLUS-INTERFERON-ALPHA-2B (IFN-CD) FOR RESISTANT OR RELAPSED MULTIPLE-MYELOMA, Experimental hematology, 22(8), 1994, pp. 734-734
Authors:
BRUGIATELLI M
FEDERICO M
GOBBI PG
AVANZINI P
CALLEA V
CAVANNA L
DEPASQUALE A
DIPRISCO AU
DIRIENZO N
SILINGARDI V
MAURI C
Citation: M. Brugiatelli et al., EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL, Haematologica, 78(5), 1993, pp. 306-312
Authors:
MORABITO F
MESSINA G
OLIVA B
RAMIREZ F
CALLEA V
BRUGIATELLI M
NOBILE F
Citation: F. Morabito et al., IN-VITRO CHEMOSENSITIVITY OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS TO MULTIDRUG REGIMEN (CEOP) COMPOUNDS USING THE MTT COLORIMETRIC ASSAY, Haematologica, 78(4), 1993, pp. 213-218
Risultati:
1-22
|